RU2020112425A3 - - Google Patents

Download PDF

Info

Publication number
RU2020112425A3
RU2020112425A3 RU2020112425A RU2020112425A RU2020112425A3 RU 2020112425 A3 RU2020112425 A3 RU 2020112425A3 RU 2020112425 A RU2020112425 A RU 2020112425A RU 2020112425 A RU2020112425 A RU 2020112425A RU 2020112425 A3 RU2020112425 A3 RU 2020112425A3
Authority
RU
Russia
Application number
RU2020112425A
Other languages
Russian (ru)
Other versions
RU2795572C2 (ru
RU2020112425A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020112425A publication Critical patent/RU2020112425A/ru
Publication of RU2020112425A3 publication Critical patent/RU2020112425A3/ru
Application granted granted Critical
Publication of RU2795572C2 publication Critical patent/RU2795572C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2020112425A 2017-09-01 2018-08-31 Соединения и композиции для ингибирования ire1 RU2795572C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762553320P 2017-09-01 2017-09-01
US62/553,320 2017-09-01
PCT/US2018/049081 WO2019046711A2 (en) 2017-09-01 2018-08-31 COMPOUNDS AND COMPOSITIONS FOR INHIBITING IRE1

Publications (3)

Publication Number Publication Date
RU2020112425A RU2020112425A (ru) 2021-10-04
RU2020112425A3 true RU2020112425A3 (enExample) 2022-03-31
RU2795572C2 RU2795572C2 (ru) 2023-05-05

Family

ID=

Also Published As

Publication number Publication date
US20200354367A1 (en) 2020-11-12
KR20200066301A (ko) 2020-06-09
EP3675858A2 (en) 2020-07-08
BR112020004226A2 (pt) 2020-11-17
CN111526877B (zh) 2023-08-25
CA3074139A1 (en) 2019-03-07
SG11202001609RA (en) 2020-03-30
US11649237B2 (en) 2023-05-16
AU2018326721A1 (en) 2020-03-12
EP3675858B1 (en) 2023-04-26
CN111526877A (zh) 2020-08-11
WO2019046711A3 (en) 2020-04-02
IL272845B2 (en) 2023-12-01
RU2020112425A (ru) 2021-10-04
IL272845A (en) 2020-04-30
ZA202001320B (en) 2023-10-25
MX2020002322A (es) 2020-10-05
EP3675858A4 (en) 2021-03-17
AU2018326721B2 (en) 2022-12-01
JP2020532589A (ja) 2020-11-12
WO2019046711A2 (en) 2019-03-07
IL272845B1 (en) 2023-08-01

Similar Documents

Publication Publication Date Title
BR112019008823A2 (enExample)
BR202018014992U2 (enExample)
BR202017025154U2 (enExample)
BR102017023327A2 (enExample)
BR202017021228U2 (enExample)
BR202017020981U2 (enExample)
BE2017C035I2 (enExample)
BR202017017068U2 (enExample)
BR202017016984U2 (enExample)
BR202017016924U2 (enExample)
BR102017015495A2 (enExample)
BR102017015250A2 (enExample)
BR102017014430A2 (enExample)
BR202017012548U2 (enExample)
BR202017011220U2 (enExample)
BR102017003115A2 (enExample)
CN303949240S9 (enExample)
CN303997571S (enExample)
CN303996627S (enExample)
CN303996071S (enExample)
CN303995829S (enExample)
CN303994903S (enExample)
CN303992994S (enExample)
CN303952054S8 (enExample)
CN303795867S9 (enExample)